Global Medical Footwear Market 2022-2028
SKU ID :TNV-12706635 | Published Date: 06-Aug-2018 | No. of pages: 125Description
TOC
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market outline
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
• Segmentation by distribution channel
• Comparison by distribution channel
• Offline distribution channel – Market size and forecast 2017-2022
• Online distribution channel – Market size and forecast 2017-2022
• Market opportunity by distribution channel
PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Men – Market size and forecast 2017-2022
• Women – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Surge in innovative product designs
• Eco-friendly medical footwear
• Rise in product visibility and accessibility through online retailing
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aetrex Worldwide
• DJO Global
• Drew Shoe
• New Balance
• OrthoFeet
PART 16: APPENDIX
• List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global medical footwear market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global medical footwear market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: Distribution channel – Market share 2017-2022 (% share of revenue)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Offline distribution channel – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Offline distribution channel – Year-over-year growth 2018-2022 (%)
Exhibit 22: Online distribution channel – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online distribution channel– Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: End-user – Market share 2017-2022 (% share of revenue)
Exhibit 26: Comparison by end-user
Exhibit 27: Men – Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Men – Year-over-year growth 2018-2022 (%)
Exhibit 29: Women – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Women – Year-over-year growth 2018-2022 (%)
Exhibit 31: Market opportunity by end-user
Exhibit 32: Geography – Market share 2017-2022 (% share of revenue)
Exhibit 33: Regional comparison
Exhibit 34: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: Diabetes prevalence in Americas in 2017
Exhibit 36: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 37: Population aged 65 and above in US (total in millions)
Exhibit 38: Population aged 65 and above in Canada (total in millions)
Exhibit 39: Population aged 65 and above in Brazil (total in millions)
Exhibit 40: Household final consumption expenditure in US 2012-2016 ($ trillions)
Exhibit 41: Household final consumption expenditure in Canada 2012-2016 ($ trillions)
Exhibit 42: Household final consumption expenditure in Brazil 2012-2016 ($ trillions)
Exhibit 43: Top 3 countries in Americas
Exhibit 44: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 45: Diabetes prevalence in EMEA in 2017
Exhibit 46: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 47: Population aged 65 and above in Germany (total in millions)
Exhibit 48: Population aged 65 and above in UK (total in millions)
Exhibit 49: Population aged 65 and above in France (total in millions)
Exhibit 50: Household final consumption expenditure in Germany 2012-2016 ($ trillions)
Exhibit 51: Household final consumption expenditure in UK 2012-2016 ($ trillions)
Exhibit 52: Household final consumption expenditure in France 2012-2016 ($ trillions)
Exhibit 53: Top 3 countries in EMEA
Exhibit 54: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 55: Diabetes prevalence in APAC in 2017
Exhibit 56: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 57: Population aged 65 and above in China (total in millions)
Exhibit 58: Population aged 65 and above in Japan (total in millions)
Exhibit 59: Population aged 65 and above in South Korea (total in millions)
Exhibit 60: Household final consumption expenditure in China 2012-2016 ($ trillions)
Exhibit 61: Household final consumption expenditure in Japan 2012-2016 ($ trillions)
Exhibit 62: Household final consumption expenditure in South Korea 2012-2016 ($ trillions)
Exhibit 63: Top 3 countries in APAC
Exhibit 64: Key leading countries
Exhibit 65: Market opportunity
Exhibit 66: Life expectancy 2010-2014 – World and regions (years)
Exhibit 67: Healthy life expectancy (years) and years lived with disability or disease burden 2010-2016 – World
Exhibit 68: Median age (of overall population) 2010-2015 – World (years)
Exhibit 69: Population aged 65 and above, total in EU and US 2010-2017 (millions)
Exhibit 70: Global population ages 65 and above, total 2010-2017 (millions)
Exhibit 71: Global population ages 65 and above 2010-2017 (% of total)
Exhibit 72: Individuals using the Internet – Worldwide 2011-2016 (% of total population)
Exhibit 73: Global mobile cellular subscriptions 2011-2016 (per 100 people)
Exhibit 74: Vendor landscape
Exhibit 75: Landscape disruption
Exhibit 76: Vendors covered
Exhibit 77: Vendor classification
Exhibit 78: Market positioning of vendors
Exhibit 79: Aetrex Worldwide – Vendor overview
Exhibit 80: Aetrex Worldwide – Business segments
Exhibit 81: Aetrex Worldwide – Organizational developments
Exhibit 82: Aetrex Worldwide – Key offerings
Exhibit 83: DJO Global – Vendor overview
Exhibit 84: DJO Global – Business portfolio
Exhibit 85: DJO Global – Organizational developments
Exhibit 86: DJO Global – Key offerings
Exhibit 87: Drew Shoe – Vendor overview
Exhibit 88: Drew Shoe – Business segments
Exhibit 89: Drew Shoe – Organizational developments
Exhibit 90: Drew Shoe – Key offerings
Exhibit 91: New Balance – Vendor overview
Exhibit 92: New Balance – Business segments
Exhibit 93: New Balance – Organizational developments
Exhibit 94: New Balance – Key offerings
Exhibit 95: OrthoFeet – Vendor overview
Exhibit 96: OrthoFeet – Business segments
Exhibit 97: OrthoFeet – Organizational developments
Exhibit 98: OrthoFeet – Key offerings
Tables & Figures
Companies
Aetrex Worldwide
DJO Global
Drew Shoe
New Balance
OrthoFeet
- PRICE
-
$2500$4000